[1] |
LIU Dan, LIU Ming, JIN Liangyou, PAN Juan, XIN Haoru, LIU Mengyuan, LI Xin, ZHENG Kun, FENG Xiaoling.
Research progress on the antitumor activity of costunolide
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1168-1176.
|
[2] |
LIU Lijing, QIAN Hong, MENG Qingxin, ZHANG Xiang, HE Bin, HE Jianbin, WEI Yingmin.
Sinomenine inhibits oxidative stress and pulmonary fibrosis by activating the Keap1/Nrf2 signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 979-987.
|
[3] |
LI Hongqin, CAO Limin, JIN Manyi, WANG Jianlong, CHAI Xiaoping, TIAN Miaomiao.
Effects of different dosage forms of Qianzheng powder on facial nerve injury in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 617-623.
|
[4] |
CHEN Cheng, DENG Yu, GONG Youlan, ZHANG Zhenming, DUAN Wulei, QING Jun, ZHANG Bo.
Research progress of the classical TCM formula Huaihua powder
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 697-704.
|
[5] |
LI Yanyang, WANG Yunjiao, LV Shichao.
Effects and mechanism of traditional Chinese medicine injection in prevention and treatment of cardiotoxicity induced by antineoplastic drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 572-577.
|
[6] |
QI Xiaofeng, LUO Yali, XIAO Mengyong, ZHOU Shiqin, ZHOU Wen, AN Fangyu, WEI Benjun, LIU Yongqi.
Research status of dialectical prevention and treatment of acute lung injury based on the theory of "Wei qi and Ying Xue"
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 429-437.
|
[7] |
DENG Ying, BAI Shutong.
Research advance of chrysoeriol on its pharmacological action and underlying mechnism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1155-1162.
|
[8] |
HE Xudong, FU Zhongyu, HUANG Ying, HE Jinbiao, PU Xuemei, LI Jie, LI Yanjuan, YU Jie, YANG Xingxin.
Research progress on chemistry and bioactivity of isopentenyl flavonoids from Sophora flavescens
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 899-907.
|
[9] |
CHEN Xi, LI Yongjun.
Effects of Chinese patent medicine for activating blood circulation on cardiac repair after myocardial infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 680-688.
|
[10] |
CHEN Shengfu, LI Xiaolin, WANG Weigang, DU Weize, LI Maoxing.
Research progress on antipyretic effect of Chinese medicine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 334-344.
|
[11] |
YU Tianyi, JIAO Guangyang, HUANG Doudou, CHEN Yong, XU Deduo, QIU Shi, CHEN Wansheng, ZHANG Feng, WANG Bolong.
Analysis of the effective components and mechanism of Yufang Fangji II for prevention of COVID-19 based on UHPLC-Q-TOF/MS and network pharmacology
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(10): 1127-1145.
|
[12] |
YIN Yujie, CHANG Liping.
Pharmacological research and clinical applications progress of Lianhua Qingwen capsules/granules in respiratory diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(10): 1174-1180.
|
[13] |
LIU Yunfan, DU Yuemei, LIU Xiaoyi, GAO Liping.
Effects of lycium barbarum polysaccharides on cis-dichlorodiamineplatinum (II)-induced apoptosis in mouse testis sertoli cells TM4#br#
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 624-630.
|
[14] |
CHEN Ying, YUAN Yonggui.
Research progress in the treatment of depression with monome of Chinese herb, drug pairs, compound prescriptions and Chinese patent drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 586-593.
|
[15] |
JING Yongshuai, ZHANG Yuwei, WU Lanfang, ZHANG Ruijuan, MA Yunfeng, ZHANG Danshen.
Research progress on extraction methods and pharmacological activities of polysaccharide from traditional Chinese herb compound
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 462-468.
|